期刊文献+

氯吡格雷抗血小板功能的两种检测方法比较 被引量:2

Antiplatelet function of clopidogrel: A comparative study of its two detection methods
原文传递
导出
摘要 目的氯吡格雷抗血小板功能的两种检测方法比较:Verifynow抗血小板治疗监测系统与流式细胞仪法。方法随机收集72例门诊、住院患者静脉血标本,同时采用Verifynow抗血小板治疗监测系统与流式细胞仪法检测血小板聚集功能。结果 Verifynow的测试结果 P2Y12Reaction Units(PRU)19例<240(26.4%);血小板膜糖蛋白分子PAC-1(Fg、Ca2+与血小板GPⅡb/Ⅲa形成复合物的受体)活性值主要集中在20-60,2例<20,12例>60;血小板膜糖蛋白分子CD62p(P选择素)活性值主要集中在10以下,3例>20;血小板膜糖蛋白分子PAC-1与CD62p活性值呈正相关(r=0.812,P<0.01);PAC-1、CD62p的活性值分别与PRU呈正相关(r=0.565,P<0.01;r=0.314,P<0.01);PRU与Verifynow测试的血小板聚集抑制百分率(INHI)呈负相关(r=-0.080 2,P<0.01)。结论 PAC-1、CD62p活性值与PRU呈正相关,相关性良好,PRU与INHI呈负相关。氯吡格雷抗血小板功能的两种检测方法存在同一性效用,但流式细胞仪法检测过程繁琐,对检验人员操作水平要求严格,若想得到药物的具体效用结果,必须在服药前、后分别抽血取样测定才能得出药物的抑制率;Verifynow操作简单快速,只需在服药后抽取一份样本即可得到样本的聚集基础值、服药后聚集值和药物的抑制率。 Objective To compare the efficiency of verifynow antiplatelet treatment monitor system and flow cytometer in detecting the antiplatelet function of clopidogrel.Methods Venous blood samples were randomly taken from 72 outpatients and inpatients.Platelet aggregation function was assayed with the verifynow antiplatelet treatment monitor system and flow cytometer.Results The P2Y12reaction unit(PRU) detected with the verifynow antiplatelet treatment monitor system was 240 in 19 individuals(26.4%).The active value of platelet membrane glucoprotein molecule PAC-1(receptor of Fg,Ca2+ and GP Ⅱb / Ⅲa complex) was 20-60 in most individuals,20 in 2 individuals,and 60 in 12 individuals.The active value of platelet membrane glucoprotein molecule CD62p(P selectin) was 10 in most individuals and 20 in 3 individuals.The active value of PAC-1 was positively correlated with that of CD62p(r=0.812,P0.01).The active value of PAC-1 and CD62p was positively correlated with the PRU(r=0.565,r=0.314,P0.01).The PRU was negatively correlated with inhibition percentage of platelet aggregation detected with the verifynow antiplatelet treatment monitor system(r=-0.080 2,P0.01).Conclusion The efficiency of verifynow antiplatelet treatment monitor system and flow cytometer is similar in detecting the antiplatelet function of clopidogrel.However,it is more tedious to use flow cytometer than to use verifynow antiplatelet treatment monitor system in detecting the antiplatelet function of clopidogrel.
出处 《军医进修学院学报》 CAS 2012年第10期1069-1070,1079,共3页 Academic Journal of Pla Postgraduate Medical School
关键词 抗血小板治疗监测系统Verifynow 抗血小板功能 血小板膜糖蛋白分子 酶原活化复合物-1 血小板活化依赖性颗粒表面膜蛋白 verifynow antiplatelet treatment monitor system antiplatelet function platelet membrane glucoprotein molecule PAC-1 CD62p
  • 相关文献

参考文献9

  • 1Zhou L, Schmaier AH. Platelet aggregation testing in platelet-rich plasma : description of procedures with the aim to develop standards in the field [ J ] . Am J Clin Pathol, 2005, 123 ( 2 ) : 172-183.
  • 2Schulman SP. Antiplatelet therapy in non-ST-segment elevation acute coronary syndromes [ J ] . JAMA, 2004, 292 ( 15 ) : 1875-1882.
  • 3Bhatt DL, Topoi EJ. Scientific and therapeutic advances in antiplatelet therapy [ J ] . Nat Rev Drug Discov, 2003, 2 ( 1 ) : 15-28.
  • 4Gurbel PA, Bliden KP, Zaman KA, et al. Clopidogrel loading with eptifibatide to arrest the reactivity of platelets : results of the Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets ( CLEAR PLATELETS ) study [ J ] . Circulation, 2005, 111 (9): 1153-1159.
  • 5蒋娟娟,田蕾,韩璐璐,严岩,黄一玲,刘红,谢爽,李一石.CYP2C9和CYP2C19基因多态性对健康中国人口服氯吡格雷后药效动力学的影响[J].中国新药杂志,2011,20(13):1217-1221. 被引量:9
  • 6李祖兰,张立文,丛玉隆,白洁,马长生,邓新立,陈兴明,杨亮程,张杰,刘波.血浆钙离子浓度对血小板聚集的影响[J].军医进修学院学报,2012,33(3):231-232. 被引量:14
  • 7CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events ( CAPRIE ) [ J ]. Lancet, 1996, 348 ( 9038 ) : 1329-1339.
  • 8Steinhubl SR, Talley JD, Braden GA, et al. Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention : results of the GOLD ( AU-Assessing Ultegra ) multicenter study [ J ] . Circulation, 2001, 103 ( 21 ) : 2572-2578.
  • 9熊丽丽,魏文宁,马怀安.应用流式细胞术检测血小板聚集及活化功能临床观察[J].现代医药卫生,2009,25(20):3041-3043. 被引量:3

二级参考文献23

  • 1熊丽丽,魏文宁.血小板微颗粒的检测方法学研究及其临床意义[J].血栓与止血学,2005,11(2):88-90. 被引量:3
  • 2邓小燕,林桢,冯桂玲.血浆Ca^(2+)浓度对血小板聚集功能的影响[J].广州医药,2005,36(5):48-49. 被引量:4
  • 3邓新立,丛玉隆,李绵洋,王俊玫.化学诱导剂对血小板钙离子浓度变化的影响[J].中华检验医学杂志,2006,29(1):55-57. 被引量:5
  • 4Carr M E.In vitro asBessment of platelet function[J].Transfus Med Rev,1997,11:106.
  • 5Michelson A D,Banard M R,Krueger L A.Evaluation of platelet function by flow cytometry[J].Methods,2002,21(3):259.
  • 6Tocchetti E V,Flower R L,Loyd J V.Assessment of in vitro-generatod platelet microparticles using a modified flow cytometric strategy[J].Thromb Res,2001,103:47.
  • 7Sakariassen KS,Holme PA,Orvim U,et al.Shear-induced platelet activation and platelet microparticle formation in native human blood[J].Thromb Res,1998,92:S33.
  • 8Abrams CS,Ellison N,Budzynski AZ,et al.Direct detection of actirated platelets and platelet-derived micmpartieles in humans[J].Blood,1990,75:128.
  • 9NGUYEN TA, DIODATI JG, PHARAND C. Resistance to clopi- dogrel: a review of the evidence[ J]. J Am Coll Cardiol, 2005, 45(8) :1157 - 1164.
  • 10WANG TH, BHATT DL,TOPOL EJ. Aspirin and clopidogrel re- sistance:an emerging clinical entity [ J ]. Eur Heart J, 2006,27 (6) : 647 - 654.

共引文献23

同被引文献14

  • 1谭大伟,朱平,李小鹰.氯吡格雷抑制血小板功能的两种检测方法比较:血小板聚集实验与血小板膜糖蛋白检测[J].中国组织工程研究与临床康复,2007,11(11):2021-2024. 被引量:11
  • 2Jeong YH,Kim IS,Choi BR,et al. The optimalthresh-old of high post-treatment platelet reactivity could bedefined by a point-of-care VerifyNow P2Y12 assay[J]. Eur Hea J,2008,29(17) :2186-2187.
  • 3Swallow RA, Agarwala RA, Dawkins KD,et al. Th-romboelastography : potential bedside tool to assessthe effects of antiplatelet therapy[J]. Platelets,2006,17(6):385-392.
  • 4Hobson AR-Petley GW, Dawkins KD,et al. A novelfifteen minute test for assessment of individual time-dependent clotting responses to aspirin and clopi-dogrel using modified thrombelastography[J]. Plate-lets, 2007,18(7) : 498-505.
  • 5Ben-Dor I, Kleiman NS? Lev E. Assesvsment, mecha-nisms ,and clinical implication of variability in plate-let response to aspirin and clopidogrel therapy [J].Am J CardioK2009,104(2) :227-233.
  • 6Latour Perez J, Navarro Ruiz A, Radiao Lopez M, et al. Using clopidogrel in non-ST-segment elevation a- cute coronary syndrome patients:a cost-utility analy- sis in Spain[J]. Value Health 2004,7 (1) : 52-60.
  • 7Ben-Dor I, Kleiman NS, Lev E. Assessment, mecha nisms,and clinical implication of variability in platelet response to aspirin and clopidogrel therapy[J]. Am J Cardiol, 2009,104(2) : 227-233.
  • 8Abrams CS, Ellison N, Budzynski AZ, et al. Direct de- tection of activated platelcts and platelet-derived mi- croparticles in humans [J]. Blood, 1990,75 ( 1 ) : 128- 138.
  • 9蒋娟娟,田蕾,韩璐璐,严岩,黄一玲,刘红,谢爽,李一石.CYP2C9和CYP2C19基因多态性对健康中国人口服氯吡格雷后药效动力学的影响[J].中国新药杂志,2011,20(13):1217-1221. 被引量:9
  • 10吴涛,刘景汉,李卉,周武,王淑英.亚硝基谷胱甘肽对冰冻血小板聚集及一氧化氮含量的影响[J].中国实验血液学杂志,2012,20(2):386-389. 被引量:7

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部